|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.645
|
Fly |
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.372
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.349
|
Fly |
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.336
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.332
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.307
|
|
|
|
sa node cell to atrial cardiac muscle cell signalling
|
GO:0086018 |
4 |
0.248
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.247
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.226
|
Fly |
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.223
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.214
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.186
|
Fly |
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.185
|
Fly |
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.181
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.180
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.172
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.172
|
Fly |
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.166
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.150
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.147
|
Fly |
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.139
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.135
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.132
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.128
|
Fly |
|
|
cartilage development
|
GO:0051216 |
140 |
0.127
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.126
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.115
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.111
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.108
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.107
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.105
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.104
|
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
85 |
0.104
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.103
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.103
|
|
|
|
regulation of ion transmembrane transporter activity
|
GO:0032412 |
54 |
0.103
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.102
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.101
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.100
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.100
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.100
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.098
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.092
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.089
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.088
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.087
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.084
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.083
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.083
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.082
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.082
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.081
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.079
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.079
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.078
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.075
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.075
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.075
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.075
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.075
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.074
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.072
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.072
|
|
|
|
regulation of striated muscle contraction
|
GO:0006942 |
25 |
0.070
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.068
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.067
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.067
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.066
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.066
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.065
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.064
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.063
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.063
|
|
|
|
potassium ion transport
|
GO:0006813 |
52 |
0.063
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.063
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.060
|
|
|
|
regulation of voltage gated calcium channel activity
|
GO:1901385 |
4 |
0.059
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.058
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.058
|
|
|
|
sa node cell action potential
|
GO:0086015 |
4 |
0.057
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.056
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.056
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.056
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.055
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.054
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.053
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.053
|
|
|
|
neurotransmitter transport
|
GO:0006836 |
76 |
0.053
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.053
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.053
|
|
|
|
regulation of cardiac muscle contraction
|
GO:0055117 |
21 |
0.053
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.052
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.052
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.052
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.051
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.051
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.050
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.050
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.049
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.048
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.048
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.048
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.048
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.048
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.048
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.047
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.047
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.047
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.046
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.046
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.046
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.046
|
|
|
|
regulation of calcium ion transmembrane transporter activity
|
GO:1901019 |
20 |
0.046
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.046
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.045
|
|
|
|
regulation of calcium ion transmembrane transport
|
GO:1903169 |
20 |
0.045
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.045
|
|
|
|
regulation of transporter activity
|
GO:0032409 |
57 |
0.045
|
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.044
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.044
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.044
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.044
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.043
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.043
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.043
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.042
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.042
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.042
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.042
|
|
|
|
calcium ion transport from endoplasmic reticulum to cytosol
|
GO:1903514 |
12 |
0.042
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.042
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.041
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.041
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.041
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.041
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.040
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.040
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.040
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.040
|
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.040
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.040
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.040
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.039
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.039
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.039
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.038
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.038
|
|
|
|
regulation of cation channel activity
|
GO:2001257 |
22 |
0.038
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.038
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.038
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.038
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.037
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.037
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.037
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.037
|
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.037
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.037
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
57 |
0.036
|
|
|
|
striated muscle hypertrophy
|
GO:0014897 |
24 |
0.036
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.035
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.035
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.035
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.035
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.035
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
49 |
0.035
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.035
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.035
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.035
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.034
|
|
|
|
brain morphogenesis
|
GO:0048854 |
32 |
0.034
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.034
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.034
|
|
|
|
negative regulation of muscle cell differentiation
|
GO:0051148 |
33 |
0.034
|
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.034
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.033
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.033
|
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.033
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.033
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.033
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.033
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.032
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.032
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.032
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.032
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.032
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.032
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.032
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.032
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.032
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.032
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.032
|
|
|
|
habituation
|
GO:0046959 |
3 |
0.032
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.031
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.031
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.031
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.031
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.030
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.030
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.030
|
|
|
|
autonomic nervous system development
|
GO:0048483 |
43 |
0.030
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.030
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.030
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.030
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.030
|
|
|
|
cellular potassium ion transport
|
GO:0071804 |
43 |
0.030
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.030
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.029
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.029
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.029
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.029
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.029
|
|
|
|
cardiac muscle cell contraction
|
GO:0086003 |
7 |
0.029
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.029
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.029
|
|
|
|
nerve development
|
GO:0021675 |
67 |
0.029
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.029
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.029
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.029
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.028
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.028
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.028
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.028
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.028
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.028
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.028
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.028
|
|
|
|
ventricular septum development
|
GO:0003281 |
42 |
0.028
|
|
|
|
positive regulation of the force of heart contraction by chemical signal
|
GO:0003099 |
3 |
0.028
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.028
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.027
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.027
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.027
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.027
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.027
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.027
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.027
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.027
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.027
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.027
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.027
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.027
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.027
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.027
|
Fly |
|
|
b cell activation
|
GO:0042113 |
161 |
0.027
|
|
|
|
epinephrine transport
|
GO:0048241 |
1 |
0.026
|
|
|
|
cell communication by electrical coupling involved in cardiac conduction
|
GO:0086064 |
2 |
0.026
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.026
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.026
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.026
|
|
|
|
positive regulation of heart rate by epinephrine norepinephrine
|
GO:0001996 |
4 |
0.026
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.026
|
|
|
|
cervix development
|
GO:0060067 |
2 |
0.026
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.026
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.026
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.026
|
Fly |
|
|
camera type eye development
|
GO:0043010 |
266 |
0.026
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.026
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.026
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.026
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.026
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.025
|
|
|
|
epinephrine secretion
|
GO:0048242 |
1 |
0.025
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.025
|
Fly |
|
|
protein import
|
GO:0017038 |
101 |
0.025
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.025
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.025
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.025
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.025
|
|
|
|
cellular modified amino acid biosynthetic process
|
GO:0042398 |
12 |
0.025
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.025
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.024
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.024
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.024
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.024
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.024
|
|
|
|
regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum
|
GO:0010880 |
10 |
0.024
|
|
|
|
operant conditioning
|
GO:0035106 |
2 |
0.024
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.024
|
|
|
|
cardiac muscle hypertrophy
|
GO:0003300 |
23 |
0.023
|
|
|
|
regulation of cardiac muscle contraction by calcium ion signaling
|
GO:0010882 |
9 |
0.023
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.023
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.023
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.023
|
|
|
|
ventricular cardiac myofibril assembly
|
GO:0055005 |
3 |
0.023
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.023
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.023
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.023
|
|
|
|
regulation of cardiac muscle cell proliferation
|
GO:0060043 |
23 |
0.023
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.023
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.022
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
59 |
0.022
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.022
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.022
|
|
|
|
negative regulation of embryonic development
|
GO:0045992 |
22 |
0.022
|
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.022
|
|
|
|
regulation of sodium ion transport
|
GO:0002028 |
29 |
0.022
|
|
|
|
catecholamine metabolic process
|
GO:0006584 |
30 |
0.022
|
|
|
|
membrane depolarization during sa node cell action potential
|
GO:0086046 |
2 |
0.022
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.022
|
|
|
|
fibroblast growth factor receptor signaling pathway
|
GO:0008543 |
46 |
0.022
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.022
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.022
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.022
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.022
|
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
61 |
0.022
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.022
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.022
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.021
|
|
|
|
regulation of morphogenesis of a branching structure
|
GO:0060688 |
53 |
0.021
|
|
|
|
prostate gland epithelium morphogenesis
|
GO:0060740 |
31 |
0.021
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.021
|
|
|
|
positive regulation of voltage gated calcium channel activity
|
GO:1901387 |
2 |
0.021
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.021
|
|
|
|
positive regulation of calcium ion transmembrane transporter activity
|
GO:1901021 |
8 |
0.021
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.021
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.021
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.021
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.021
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.021
|
|
|
|
adult walking behavior
|
GO:0007628 |
41 |
0.021
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.021
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.021
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.021
|
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.020
|
|
|
|
positive regulation of ion transmembrane transport
|
GO:0034767 |
24 |
0.020
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.020
|
|
|
|
positive regulation of heart contraction
|
GO:0045823 |
14 |
0.020
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.020
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.020
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.020
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.020
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.020
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.020
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.020
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.020
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.020
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.020
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.020
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.020
|
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.020
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.020
|
|
|
|
positive regulation of calcium ion transport
|
GO:0051928 |
27 |
0.020
|
|
|
|
phenol containing compound metabolic process
|
GO:0018958 |
60 |
0.020
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.019
|
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
57 |
0.019
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.019
|
|
|
|
cardiac conduction
|
GO:0061337 |
17 |
0.019
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
87 |
0.019
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.019
|
|
|
|
ventral spinal cord development
|
GO:0021517 |
48 |
0.019
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.019
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.019
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.019
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.019
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.019
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.019
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.019
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.019
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.018
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.018
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.018
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.018
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.018
|
|
|
|
regulation of neuronal synaptic plasticity
|
GO:0048168 |
30 |
0.018
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.018
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.018
|
|
|
|
catecholamine transport
|
GO:0051937 |
21 |
0.018
|
|
|
|
pituitary gland development
|
GO:0021983 |
38 |
0.018
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.018
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.018
|
Fly |
|
|
sterol homeostasis
|
GO:0055092 |
45 |
0.018
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
53 |
0.018
|
|
|
|
ventricular cardiac muscle cell action potential
|
GO:0086005 |
4 |
0.018
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.018
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.018
|
|
|
|
b cell activation involved in immune response
|
GO:0002312 |
50 |
0.018
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.018
|
|
|
|
regulation of cardiac muscle tissue development
|
GO:0055024 |
31 |
0.018
|
|
|
|
positive regulation of b cell activation
|
GO:0050871 |
49 |
0.017
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.017
|
Fly |
|
|
response to muscle stretch
|
GO:0035994 |
1 |
0.017
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.017
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.017
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.017
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.017
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.017
|
|
|
|
monocarboxylic acid transport
|
GO:0015718 |
44 |
0.017
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.017
|
|
|
|
protein alkylation
|
GO:0008213 |
81 |
0.017
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.017
|
|
|
|
trabecula morphogenesis
|
GO:0061383 |
40 |
0.017
|
|
|
|
transition metal ion homeostasis
|
GO:0055076 |
54 |
0.017
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.017
|
|
|
|
negative regulation of type b pancreatic cell apoptotic process
|
GO:2000675 |
3 |
0.017
|
|
|
|
potassium ion transmembrane transport
|
GO:0071805 |
43 |
0.017
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.017
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.017
|
|
|
|
neurotransmitter uptake
|
GO:0001504 |
14 |
0.016
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.016
|
|
|
|
cell cell signaling involved in cell fate commitment
|
GO:0045168 |
35 |
0.016
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.016
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.016
|
|
|
|
regulation of engulfment of apoptotic cell
|
GO:1901074 |
2 |
0.016
|
|
|
|
long chain fatty acid transport
|
GO:0015909 |
15 |
0.016
|
|
|
|
lung alveolus development
|
GO:0048286 |
45 |
0.016
|
|
|
|
translation
|
GO:0006412 |
93 |
0.016
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.016
|
|
|
|
ventricular cardiac muscle cell differentiation
|
GO:0055012 |
17 |
0.016
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.016
|
Fly |
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.016
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.016
|
|
|
|
atp catabolic process
|
GO:0006200 |
55 |
0.016
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.016
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.016
|
|
|
|
positive regulation of heart rate
|
GO:0010460 |
10 |
0.016
|
|
|
|
glial cell development
|
GO:0021782 |
54 |
0.016
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.016
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.016
|
|
|
|
negative regulation of purine nucleotide metabolic process
|
GO:1900543 |
16 |
0.016
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.016
|
|
|
|
dna recombination
|
GO:0006310 |
92 |
0.016
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.016
|
|
|
|
syncytium formation
|
GO:0006949 |
43 |
0.016
|
|
|
|
single fertilization
|
GO:0007338 |
82 |
0.016
|
|
|
|
planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:0061348 |
2 |
0.016
|
|
|
|
cytokine biosynthetic process
|
GO:0042089 |
68 |
0.016
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.016
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.016
|
|
|
|
positive regulation of cardiac muscle contraction
|
GO:0060452 |
2 |
0.016
|
|
|
|
regulation of heart rate
|
GO:0002027 |
36 |
0.016
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.016
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.016
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.015
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.015
|
|
|
|
muscle hypertrophy
|
GO:0014896 |
24 |
0.015
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.015
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.015
|
|
|
|
harderian gland development
|
GO:0070384 |
2 |
0.015
|
|
|
|
cochlea development
|
GO:0090102 |
35 |
0.015
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.015
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.015
|
|
|
|
defecation
|
GO:0030421 |
1 |
0.015
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.015
|
|
|
|
forelimb morphogenesis
|
GO:0035136 |
40 |
0.015
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.015
|
|
|
|
protein kinase c activating g protein coupled receptor signaling pathway
|
GO:0007205 |
4 |
0.015
|
|
|
|
learning
|
GO:0007612 |
98 |
0.015
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.015
|
|
|
|
transcription factor import into nucleus
|
GO:0042991 |
26 |
0.015
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.015
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
47 |
0.015
|
|
|
|
positive regulation of ossification
|
GO:0045778 |
47 |
0.015
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.015
|
|
|
|
polarity specification of proximal distal axis
|
GO:0010085 |
2 |
0.015
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.015
|
|
|
|
canonical wnt signaling pathway involved in regulation of cell proliferation
|
GO:0044340 |
3 |
0.015
|
|
|
|
spemann organizer formation
|
GO:0060061 |
2 |
0.015
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.015
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.015
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.015
|
|
|
|
positive regulation of muscle tissue development
|
GO:1901863 |
32 |
0.015
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.015
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.014
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.014
|
Fly |
|
|
action potential
|
GO:0001508 |
78 |
0.014
|
Fly |
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.014
|
|
|
|
protein glycosylation
|
GO:0006486 |
55 |
0.014
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.014
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.014
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.014
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.014
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.014
|
Fly |
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.014
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.014
|
|
|
|
visual behavior
|
GO:0007632 |
45 |
0.014
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.014
|
|
|
|
regulation of acetylcholine secretion neurotransmission
|
GO:0014056 |
2 |
0.014
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.014
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.014
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.014
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.014
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.014
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.014
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.014
|
|
|
|
regulation of protein targeting
|
GO:1903533 |
61 |
0.014
|
|
|
|
protein homooligomerization
|
GO:0051260 |
43 |
0.014
|
|
|
|
regulation of long term neuronal synaptic plasticity
|
GO:0048169 |
19 |
0.014
|
|
|
|
histamine uptake
|
GO:0051615 |
1 |
0.014
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.014
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.014
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.014
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.014
|
|
